1. Home
  2. ZVRA vs HBCP Comparison

ZVRA vs HBCP Comparison

Compare ZVRA & HBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZVRA
  • HBCP
  • Stock Information
  • Founded
  • ZVRA 2006
  • HBCP 1908
  • Country
  • ZVRA United States
  • HBCP United States
  • Employees
  • ZVRA N/A
  • HBCP N/A
  • Industry
  • ZVRA Biotechnology: Pharmaceutical Preparations
  • HBCP Banks
  • Sector
  • ZVRA Health Care
  • HBCP Finance
  • Exchange
  • ZVRA Nasdaq
  • HBCP Nasdaq
  • Market Cap
  • ZVRA 467.6M
  • HBCP 421.4M
  • IPO Year
  • ZVRA 2015
  • HBCP 2008
  • Fundamental
  • Price
  • ZVRA $8.99
  • HBCP $54.39
  • Analyst Decision
  • ZVRA Strong Buy
  • HBCP Buy
  • Analyst Count
  • ZVRA 7
  • HBCP 2
  • Target Price
  • ZVRA $21.71
  • HBCP $63.50
  • AVG Volume (30 Days)
  • ZVRA 1.5M
  • HBCP 24.7K
  • Earning Date
  • ZVRA 11-05-2025
  • HBCP 10-20-2025
  • Dividend Yield
  • ZVRA N/A
  • HBCP 2.26%
  • EPS Growth
  • ZVRA N/A
  • HBCP 24.56
  • EPS
  • ZVRA 0.54
  • HBCP 5.62
  • Revenue
  • ZVRA $84,388,000.00
  • HBCP $145,087,000.00
  • Revenue This Year
  • ZVRA $336.43
  • HBCP $2.60
  • Revenue Next Year
  • ZVRA $54.26
  • HBCP $3.27
  • P/E Ratio
  • ZVRA $16.52
  • HBCP $9.75
  • Revenue Growth
  • ZVRA 244.60
  • HBCP 11.42
  • 52 Week Low
  • ZVRA $6.19
  • HBCP $39.59
  • 52 Week High
  • ZVRA $13.16
  • HBCP $61.07
  • Technical
  • Relative Strength Index (RSI)
  • ZVRA 38.60
  • HBCP 51.28
  • Support Level
  • ZVRA $8.51
  • HBCP $53.14
  • Resistance Level
  • ZVRA $9.69
  • HBCP $55.55
  • Average True Range (ATR)
  • ZVRA 0.58
  • HBCP 1.07
  • MACD
  • ZVRA -0.15
  • HBCP 0.14
  • Stochastic Oscillator
  • ZVRA 15.26
  • HBCP 58.86

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

About HBCP Home Bancorp Inc.

Home Bancorp Inc is engaged in attracting deposits from the public and using those funds to invest in loans and securities. The principal sources of funds are customer deposits, repayments of loans, repayments of investments and funds borrowed from outside sources such as the Federal Home Loan Bank of Dallas. These funds are used for the origination of loans, including one-to-four-family first mortgage loans, home equity loans, and lines, commercial real estate loans, construction and land loans, multi-family residential loans, commercial and industrial loans, and consumer loans.

Share on Social Networks: